RTI Surgical completed its previously-announced acquisition of Paradigm Spine, and is integrating the coflex® Interlaminar Stabilization® device into RTI’s portfolio.
The minimally invasive coflex implant is FDA Premarket Approved to treat moderate to severe lumbar spinal stenosis alongside decompression. coflex has wide payor coverage in the U.S., and in 2016, ISASS issued recommendations and coverage criteria for decompression with interlaminar stabilization for select patients with lumbar spinal stenosis.
RTI Surgical completed its previously-announced acquisition of Paradigm Spine, and is integrating the coflex® Interlaminar Stabilization® device into RTI's portfolio.
The minimally invasive coflex implant is FDA Premarket Approved to treat moderate to severe lumbar spinal stenosis alongside decompression. coflex has wide payor coverage in the...
RTI Surgical completed its previously-announced acquisition of Paradigm Spine, and is integrating the coflex® Interlaminar Stabilization® device into RTI’s portfolio.
The minimally invasive coflex implant is FDA Premarket Approved to treat moderate to severe lumbar spinal stenosis alongside decompression. coflex has wide payor coverage in the U.S., and in 2016, ISASS issued recommendations and coverage criteria for decompression with interlaminar stabilization for select patients with lumbar spinal stenosis.
Copy to clipboard 
